期刊文献+

螺光黑壳菌酮A腹腔注射对昆明小鼠半数致死量的测定 被引量:1

Determination the median lethal dose to kunming mouse of Spiropreussione A by intraperitoneal injection
暂未订购
导出
摘要 目的用寇氏法测定螺光黑壳菌酮A腹腔注射对昆明小鼠的半数致死量(median lethal dose,LD50)。方法实验动物为啮齿昆明小鼠,雌雄各半,体重(20±2)g。用序贯法摸索出受试物的全死剂量,而后设置5个剂量组,剂量比值r=1.25(或0.80)。一次性腹腔注射黑壳菌酮A后,连续观察10 d,统计各组死亡情况并计算半数致死剂量。结果各组小鼠均出现不同程度的腹腔刺激反应,雌性比雄性反应更强烈且呈剂量依赖性,30 min后刺激基本消失;受试物腹腔注射LD50为5.35 mg/kg,其95%可信区间为4.69~6.11 mg/kg。结论螺光黑壳菌酮A的LD50为5.35 mg/kg,死亡率呈剂量依赖性。 Objective Karber' s method was applied to test the median lethal dose ( LD50 ) of Spiropreussione A in KM mice by intraperitoneal injection. Methods KM mice which half is male and another half is female were used to measure 100% lethal dose by Sequential method first, the rest was divided into 5 groups randomly. The ratio of high dose group and low dose group is set up as 1.25 ( or 0. 8 ). Then the KM mice were administered Spiropreussione A at different dosages through intraperitoneal injection. Toxicity symptoms and times of death of the mice were recorded, and LD50 of Spiropreussione A on mice was calculated. Results Different degrees of peritoneal irritation were observed in each group and it was more significant in female than male. The peritoneal irritation disappeared after 30 min. The LD50 of Spiropreussione A was 5.35mg/kg, 95% confidence interval was (4.69 -6. 11 ) mg/kg. Conclusion This experiment showed that the LD50 of Spiropreussione A is 5.35 mg/kg and the mortality is dose-dependent.
出处 《中国比较医学杂志》 CAS 2013年第7期25-28,共4页 Chinese Journal of Comparative Medicine
基金 "重大新药创制"科技重大专项 项目编号:2012ZX09301002-001-032
关键词 急性毒性 半数致死量 Spiropreussione A, Acute toxicity, Median lethal dose
  • 相关文献

参考文献10

  • 1Yang YE,Xi-Qiang LI,Chun-Ping TANG.Natural Products Chemistry Research 2009's Progress in China[J].Chinese Journal of Natural Medicines.2011,9(1):0007-0016.
  • 2Xiaomei Chen,Qiyuan Shi,Shunxing Guo,et al.Spirobisnaphthalene Analogues from the Endophytic Fungus Preussia sp.[J].J Nat Prod.2009,72:1712-1715.
  • 3CDER,FDA.Guidance for industry:single dose acute toxicity testing for pharmaceuticals (Final).1996.
  • 4OECD.Guideline 425:Acute Oral Toxicity-Up and Down Procedure.OECD Guidelines for testing of chemicals.2001.
  • 5梁磊,张绪慧,王晓燕,邓虹珠.腹腔注射槐定碱的急性毒性实验[J].时珍国医国药,2011,22(5):1252-1253. 被引量:4
  • 6Finney D.J.The median lethal dose and its estimation[J].Arch Toxicol.1985,56:215-218.
  • 7国家食品药品监督管理局.化学药物急性毒性试验技术指导原则,1995.
  • 8Sperling F.Nonlethal parameters as indices of acute toxicity:inadequacy of the acute LD50[M].John Wiley and Sous,New York London Sydney Toronto.1976,177.
  • 9Zbinden G.and Flury-Roversi M.Significance of the LD50-Test for the Toxicological Evaluation of Chemical Substances[J].Arch Toxicol.1981,47:77-99.
  • 10Powis G.Wipf P.Stephen M.L.et al.Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase[J].Mol.Cancer Ther.2006,5(3):630-636.

二级参考文献9

共引文献3

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部